Jazz Pharmaceuticals traded at $150.07 this Friday May 20th, increasing $0.54 or 0.36 percent since the previous trading session. Looking back, over the last four weeks, Jazz Pharmaceuticals gained 10.67 percent. Over the last 12 months, its price fell by 15.97 percent. Looking ahead, we forecast Jazz Pharmaceuticals to be priced at 139.54 by the end of this quarter and at 124.54 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
150.07
Daily Change
0.36%
Yearly
-15.97%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 151.16 -0.84 -0.55% 30.18%
Aerie Pharmaceuticals 7.02 -0.12 -1.68% -60.78%
ALKERMES 30.39 0.91 3.09% 38.64%
Amarin 1.43 -0.02 -1.04% -68.75%
Antares Pharma 5.59 0.01 0.18% 37.01%
Cara Therapeutics 8.75 0.22 2.58% -34.06%
Coherus Biosciences 8.21 0.30 3.85% -39.06%
Emergent BioSolutions 34.36 2.67 8.43% -41.41%
Endo International 0.46 -0.11 -19.56% -91.69%
Halozyme Therapeutics 44.43 0.59 1.35% 4.08%
Hikma Pharmaceutical 1,744.50 41.00 2.41% -29.00%
Heron Therapeutics 3.70 0.13 3.68% -74.03%
Horizon Pharma 90.30 0.96 1.07% -3.92%
Ionis Pharmaceuticals 39.15 0.02 0.05% 7.08%
Lannett 0.53 0.003 0.65% -88.72%
Eli Lilly 299.17 12.90 4.51% 49.67%
McKesson 323.00 3.87 1.21% 59.36%
Merck & Co 93.58 1.49 1.62% 18.19%
Nektar Therapeutics 4.00 0.09 2.30% -77.96%
Phibro Animal Health 18.22 0.29 1.59% -36.71%
Pacira 63.72 0.68 1.08% -3.91%
Pfizer 52.49 1.84 3.63% 31.39%
Perrigo 38.11 0.53 1.41% -16.79%
Revance Therapeutics 14.13 0.33 2.39% -49.77%
Supernus Pharmaceuticals 27.33 0.22 0.81% -12.57%
Teva Pharmaceutical Industries 8.48 0.17 2.05% -21.26%
Xeris Pharmaceuticals Inc 2.22 0.02 0.68% -36.71%
Zoetis 161.57 2.94 1.85% -8.09%


Jazz Pharmaceuticals
Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for the treatment of acute lymphoblastic leukemia (ALL), and Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease (VOD). The Company also commercializes Prialt, an intrathecally administered infusion of ziconotide, approved by the FDA for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies or intrathecal morphine.